Biotechnology, Science, Research, Startup, Pharmaceutical.
also have high failure rates and require specialized knowledge. Without access to 3D tissue scaffolds that have circulation or microvasculature as architecture, scientists haven’t been able to grow dense cell-laden tissue — the type needed to support the cell-cell interactions that drive gene